Related scientific articles (all)

Recent advances in radiosensitivity determinants in melanoma.

Authors : Krayem M, Ghanem GE, Van Gestel D
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 131-138

Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.

Authors : Yanni A, Buset T, Bouland C, Loeb I, Lechien JR, Rodriguez A, Journe F, Saussez S, Dequanter D
Year : 2022
Journal : Eur Arch Otorhinolaryngol
Volume : 279
Pages : 4103-4111

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors : Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE
Year : 2022
Journal : Cells
Volume : 11

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease.

Authors : AlGhamdi H, Dhont J, Krayem M, De Bruyn P, Engels B, Van Gestel D, Van den Begin R
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.

Authors : Chouha N, Abou-Hamdan H, Yurugi H, Yoshii R, Ii H, Najem A, Ghanem GE, Nakata S, Rajalingam K, Peng Y, Wang D, Nebigil CG, Désaubry L
Year : 2022
Journal : Eur J Med Chem
Volume : 242
Pages : 114635

Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer.

Authors : Descamps G, Furgiuele S, Mhaidly N, Journe F, Saussez S
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.

Authors : Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, Ghanem GE, Hendlisz A
Year : 2022
Journal : Cells
Volume : 11

Bufalin for an innovative therapeutic approach against cancer.

Authors : Soumoy L, Ghanem GE, Saussez S, Journe F
Year : 2022
Journal : Pharmacol Res
Volume : 184
Pages : 106442

Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers.

Authors : Furgiuele S, Descamps G, Cascarano L, Boucq A, Dubois C, Journe F, Saussez S
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110].

Authors : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Salès F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G
Year : 2022
Journal : Eur J Cancer
Volume : 175
Pages : 336-338

Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.

Authors : Furgiuele S, Descamps G, Lechien JR, Dequanter D, Journe F, Saussez S
Year : 2022
Journal : Cells
Volume : 11

Cytokine Landscape in Central Nervous System Metastases.

Authors : Marin J, Journe F, Ghanem GE, Awada A, Kindt N
Year : 2022
Journal : Biomedicines
Volume : 10

The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells.

Authors : Ajouaou Y, Azouz A, Taquin A, Denanglaire S, Hussein H, Krayem M, Andris F, Moser M, Goriely S, Leo O
Year : 2022
Journal : Elife
Volume : 11

Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells.

Authors : Scalia A, Kindt N, Trelcat A, Nachtergael A, Duez P, Journé F, Carlier S
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.

Authors : de Bakker T, Journe F, Descamps G, Saussez S, Dragan T, Ghanem G, Krayem M, Van Gestel D
Year : 2021
Journal : Front Oncol
Volume : 11
Pages : 799993

Downregulation of the FTO m⁶A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors.

Authors : Jeschke J, Collignon E, Al Wardi C, Krayem M, Bizet M, Jia Y, Garaud S, Wimana Z, Calonne E, Hassabi B, Morandini R, Deplus R, Putmans P, Dube G, Singh NK, Koch A, Shostak K, Rizzotto L, Ross RL, Desmedt C, Bareche Y, Rothé F, Lehmann-Che J, Duterque-Coquillaud M, Leroy X, Menschaert G, Teixeira L, Guo M, Limbach PA, Close P, Chariot A, Leucci E, Ghanem G, Yuan BF, Willard-Gallo K, Sotiriou C, Marine JC, Fuks F
Year : 2021
Journal : Nat Cancer
Volume : 2
Pages : 611-628

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value.

Authors : Najem A, Wouters J, Krayem M, Rambow F, Sabbah M, Sales F, Awada A, Aerts S, Journe F, Marine JC, Ghanem GE
Year : 2021
Journal : Front Oncol
Volume : 11
Pages : 780654

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research.

Authors : Cogels MM, Rouas R, Ghanem GE, Martinive P, Awada A, Van Gestel D, Krayem M
Year : 2021
Journal : Front Oncol
Volume : 11
Pages : 784947

Survival and treatment outcome of head and neck cancer patients with pulmonary oligometastases.

Authors : Lardinois I, Dequanter D, Lechien JR, Bouland C, Javadian R, Rodriguez A, Loeb I, Journe F, Saussez S
Year : 2021
Journal : Clin Otolaryngol
Volume : 46
Pages : 311-317

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.

Authors : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Year : 2021
Journal : Mol Cancer Res
Volume : 19
Pages : 1221-1233